# Lung Cancer Symptom Assessment and Management Intervention

> **NCT00852462** · PHASE2 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 179 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BEHAVIORAL:** SAMI

## Key facts

- **NCT ID:** NCT00852462
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2012-08
- **Final completion:** 2016-06
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2016-10-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852462, "Lung Cancer Symptom Assessment and Management Intervention". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00852462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*